Nunzia Pharmaceutical Company (NUNZ)

NUNZ Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	0.03	0	-	-	-	-
Cash & Short-Term Investments	0.04	0	-	-	-	-
Total Current Assets	0.04	0	-	-	-	-
Long-Term Investments	-	0.01	-	-	-	-
Total Assets	0.04	0.01	-	-	-	-
Accounts Payable	0.04	0	0.03	0.02	0.06	0.07
Short-Term Debt	0.18	0.1	0.01	-	0.02	0.02
Other Current Liabilities	-	-	-	0	0.21	0.18
Total Current Liabilities	0.23	0.1	0.04	0.02	0.29	0.28
Long-Term Debt	-	-	0.02	-	-	-
Total Liabilities	0.23	0.1	0.06	0.02	0.29	0.28
Common Stock	0.43	0.43	0.24	0.23	0.15	0.15
Additional Paid-In Capital	197.74	178.85	92.01	0.03	-	-
Retained Earnings	-198.39	-179.41	-101.35	-0.33	-0.3	-0.28
Comprehensive Income & Other	0.03	0.03	9.04	0.05	-0.14	-0.14
Shareholders' Equity	-0.19	-0.09	-0.06	-0.02	-0.29	-0.28
Total Liabilities & Equity	0.04	0.01	-	-	-	-
Total Debt	0.18	0.1	0.03	-	0.02	0.02
Net Cash (Debt)	-0.15	-0.1	-0.03	-	-0.02	-0.02
Net Cash Per Share	-0.00	-0.00	-0.00	-	-1.10	-1.10
Filing Date Shares Outstanding	434.51	434.12	256.12	409.9	0.02	0.02
Total Common Shares Outstanding	434.51	434.12	244.37	409.9	0.02	0.02
Working Capital	-0.19	-0.1	-0.04	-0.02	-0.29	-0.28
Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-14.02	-13.13
Tangible Book Value	-0.19	-0.09	-0.06	-0.02	-0.29	-0.28
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-14.02	-13.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.